Immune thrombocytopenia of haematological immune-related adverse events in cancer immunotherapy: Most and mighty
Eur J Cancer
.
2020 May:131:16-17.
doi: 10.1016/j.ejca.2020.02.042.
Epub 2020 Apr 2.
Authors
Xiaocong Pang
1
,
Xian Su
2
,
Zhuo Zhang
1
,
Yimin Cui
3
Affiliations
1
Department of Pharmacy, Peking University First Hospital, Beijing, China.
2
Centre for Drug Evaluation, National Medical Products Administration, Beijing, China.
3
Department of Pharmacy, Peking University First Hospital, Beijing, China. Electronic address: cui.pharm@pkufh.com.
PMID:
32248070
DOI:
10.1016/j.ejca.2020.02.042
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Immunologic Factors
Immunotherapy
Neoplasms*
Purpura, Thrombocytopenic, Idiopathic*
Thrombocytopenia*
Substances
Immunologic Factors